ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer
Open Access
- 7 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 787897
Abstract
Background: Recent studies have confirmed that AT-rich interactive domain-containing protein 1A (ARID1A) plays a critical role in tumorigenesis, but its role in gallbladder cancer (GBC) remains unclear.Methods: In total, 224 patients from Zhongshan Hospital were recruited for this retrospective study. The clinicopathological and baseline characteristics of the patients were collected. Bioinformatics analysis was performed to reveal variations in genes and signaling pathways, and ARID1A and PD-L1 expression and the number of PD1+ tumor-infiltrating lymphocytes (TILs) were measured by immunohistochemical staining.Results: ARID1A expression was negatively correlated with overall survival in patients with GBC, and multivariate analysis identified ARID1A as an independent prognostic factor for overall survival. A heatmap and gene set enrichment analysis suggested that cytotoxic T lymphocyte signatures and immune-related signaling pathways were downregulated in ARID1A low tumors. Subsequent immunohistochemical staining confirmed that ARID1A expression was negatively correlated with PD-L1 expression and PD1+ TILs in the tumor microenvironment. The Kaplan–Meier analysis suggested that high ARID1A expression combined with low PD-L1 expression or low PD1+ TIL counts is associated with the best prognosis in patients with GBC.Conclusion: ARID1A inactivation can lead to a worse prognosis in patients with GBC, potentially by mediating immune evasion through the PD1/PD-L1 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81872352, 82002525)
This publication has 39 references indexed in Scilit:
- Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studiesScientific Reports, 2016
- Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary CarcinomasAmerican Journal of Clinical Pathology, 2016
- Genomics of gallbladder cancer: the case for biomarker-driven clinical trial designCancer and Metastasis Reviews, 2016
- Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2015
- Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinomaHistopathology, 2015
- Discovery and saturation analysis of cancer genes across 21 tumour typesNature, 2014
- Carcinoma of the gallbladder: Patterns of presentation, prognostic factors and survival rate. An 11-year single centre experienceEuropean Journal of Surgical Oncology, 2013
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse FunctionsJournal of Biological Chemistry, 2012
- The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexesNucleic Acids Research, 2004